Nath Bio-Genes (India) Limited (NATHBIOGEN) — Free Cash Flow Generation Index
Nath Bio-Genes (India) Limited (NATHBIOGEN) has a Free Cash Flow Generation Index of 1.45x as of March 2025. Free cash flow of Rs255.02 Million represents 1% of operating cash flow (Rs175.81 Million). Explore Nath Bio-Genes (India) Limited capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Nath Bio-Genes (India) Limited Free Cash Flow Generation Index (2013–2025)
Historical FCF Generation Index trend for Nath Bio-Genes (India) Limited across 10 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Nath Bio-Genes (India) Limited.
Annual Free Cash Flow Generation for Nath Bio-Genes (India) Limited (2013–2025)
Year-by-year Free Cash Flow Generation Index for Nath Bio-Genes (India) Limited. Check how aggressively does Nath Bio-Genes (India) Limited reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (INR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.55x | Rs96.61 Million | Rs175.81 Million | Rs79.20 Million | ▼ -36.4% |
| 2024 | 0.86x | Rs530.87 Million | Rs614.80 Million | Rs83.93 Million | ▼ -7.5% |
| 2023 | 0.93x | Rs358.18 Million | Rs383.67 Million | Rs25.49 Million | ▲ +500.8% |
| 2022 | -0.23x | Rs-39.70 Million | Rs170.46 Million | Rs210.17 Million | ▲ +97.5% |
| 2021 | -9.42x | Rs-104.86 Million | Rs11.13 Million | Rs115.98 Million | ▼ -1226.6% |
| 2020 | -0.71x | Rs-67.29 Million | Rs94.74 Million | Rs162.03 Million | ▼ -203.5% |
| 2017 | -0.23x | Rs-7.82 Million | Rs33.43 Million | Rs41.26 Million | ▼ -126.1% |
| 2015 | 0.90x | Rs60.49 Million | Rs67.55 Million | Rs7.06 Million | ▲ +10.9% |
| 2014 | 0.81x | Rs121.33 Million | Rs150.28 Million | Rs28.95 Million | ▲ +260.6% |
| 2013 | -0.50x | Rs-71.43 Million | Rs142.11 Million | Rs213.54 Million | — |